WHO prioritises clinical trials for Bundibugyo Ebola treatments, vaccines
Health experts have advised that all candidate treatments and vaccines for Ebola disease caused by the Bundibugyo virus should be used exclusively within clinical trials to ensure safe, ethical, and effective research. A statement made available on Thursday said that the experts were convened by the...
Sentiment: Positive (
0.80
)
Bias: Neutral
Fact-Checked Information
Source:
Google Fact Check Tools
Reliability:
Unknown
Notes:
No fact-checks found for this content
Verified on May 29, 2026